Arbutus Biopharma Corp CEO Mark Murray's 2018 pay jumps 32% to $2.5M
Arbutus Biopharma Corp reports 2018 executive compensation
By ExecPay News
Published: April 23, 2019
Arbutus Biopharma Corp reported fiscal year 2018 executive compensation information on April 23, 2019.
In 2018, three executives at Arbutus Biopharma Corp received on average a compensation package of $1.8M, a 77% increase compared to previous year.
Average pay of disclosed executives at Arbutus Biopharma Corp
Mark Murray, Chief Executive Officer, received $2.5M in total, which increased by 32% compared to 2017. 64% of Murray's compensation, or $1.6M, was in option awards. Murray also received $306K in non-equity incentive plan, $556K in salary, as well as $56K in other compensation.
Gaston Picchio, Chief Development Officer, received a compensation package of $1.5M. 92% of the compensation package, or $1.4M, was in option awards.
David C. Hastings, Chief Financial Officer, earned $1.5M in 2018.
Related executives
You may also like
Source: SEC filing on April 23, 2019.